Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Other Non-Current Liabilities (2018 - 2021)

Cue Biopharma (CUE) has disclosed Other Non-Current Liabilities for 4 consecutive years, with $89000.0 as the latest value for Q2 2021.

  • Quarterly Other Non-Current Liabilities changed N/A to $89000.0 in Q2 2021 from the year-ago period, while the trailing twelve-month figure was $89000.0 through Jun 2021, changed N/A year-over-year, with the annual reading at $1.9 million for FY2020, 51.78% down from the prior year.
  • Other Non-Current Liabilities hit $89000.0 in Q2 2021 for Cue Biopharma, down from $1.3 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $6.4 million in Q2 2019 to a low of $89000.0 in Q2 2021.
  • Historically, Other Non-Current Liabilities has averaged $2.9 million across 4 years, with a median of $2.5 million in 2020.
  • Biggest five-year swings in Other Non-Current Liabilities: skyrocketed 774.37% in 2019 and later plummeted 76.78% in 2020.
  • Year by year, Other Non-Current Liabilities stood at $5.2 million in 2018, then fell by 22.36% to $4.0 million in 2019, then tumbled by 51.78% to $1.9 million in 2020, then tumbled by 95.41% to $89000.0 in 2021.
  • Business Quant data shows Other Non-Current Liabilities for CUE at $89000.0 in Q2 2021, $1.3 million in Q1 2021, and $1.9 million in Q4 2020.